Computerized Cognitive Test to Screen for Cognitive Changes in Patients with Multiple Myeloma

Overview

About this study

The purpose of this study is to measure subtle cognitive changes by using a simple and brief computer-based test (CogState Battery) in patients with Multiple Myeloma treated at Mayo Clinic in Scottsdale, Arizona.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Willingness to undergo cognitive testing and participate in the feasibility study
Confirmed diagnosis of multiple myeloma
Treatment with chemotherapy medications (e.g. lenalidomide, pomalidomide) after stem cell transplantation
Age ≥ 40 years
Provide written informed consent

Exclusion Criteria:

Unwillingness or inability to undergo cognitive testing
Other diagnosed medical conditions that might interfere with cognitive testing (e.g. visual impairment, neuropsychiatric disorders)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Yonas Geda, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Yonas Geda, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials